Home > PJ (current issue) > Articles

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7383 p43-44
14 January 2006

This article
Reprint   Photocopy

PDF 90K, Acrobat Reader

Articles

Possible treatments for hepatitis C — what's currently in the pipeline?

Most of the 200,000 people in the UK who are chronically infected with hepatitis C are not aware of the fact and the incidence of resulting liver disease is predicted to rise. Jenny Bryan looks at recent developments in the search for hepatitis C treatments


PDF 90K, Acrobat Reader


Back to Top

©The Pharmaceutical Journal